Page last updated: 2024-08-22

didodecyldimethylammonium and Cancer of Skin

didodecyldimethylammonium has been researched along with Cancer of Skin in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Carbone, C; Furneri, PM; Martins-Gomes, C; Musumeci, T; Pepe, V; Puglisi, G; Silva, AM; Souto, EB	1

Other Studies

1 other study(ies) available for didodecyldimethylammonium and Cancer of Skin

Article	Year
Repurposing itraconazole to the benefit of skin cancer treatment: A combined azole-DDAB nanoencapsulation strategy. Colloids and surfaces. B, Biointerfaces, 2018, Jul-01, Volume: 167 Topics: Antineoplastic Agents; Azoles; Cell Proliferation; Cell Survival; Cells, Cultured; Dose-Response Relationship, Drug; Drug Delivery Systems; Drug Repositioning; Drug Screening Assays, Antitumor; Humans; Itraconazole; Lipids; Nanoparticles; Particle Size; Quaternary Ammonium Compounds; Skin Neoplasms; Structure-Activity Relationship; Surface Properties	2018

Article

Year

Repurposing itraconazole to the benefit of skin cancer treatment: A combined azole-DDAB nanoencapsulation strategy.

Colloids and surfaces. B, Biointerfaces, 2018, Jul-01, Volume: 167

Topics: Antineoplastic Agents; Azoles; Cell Proliferation; Cell Survival; Cells, Cultured; Dose-Response Relationship, Drug; Drug Delivery Systems; Drug Repositioning; Drug Screening Assays, Antitumor; Humans; Itraconazole; Lipids; Nanoparticles; Particle Size; Quaternary Ammonium Compounds; Skin Neoplasms; Structure-Activity Relationship; Surface Properties

2018